尿路結石管理機器の世界市場分析:治療別(体外衝撃波砕石術(ESWL)、体内砕石術、経皮的腎結石、他の治療(経過観察、副甲状腺手術))、エンドユーザー別(病院・診療所、外来手術センター)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Urolithiasis Management Devices Market Analysis By Treatment Type (Extracorporeal Shock Wave Lithotripsy (Eswl), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatments (Watchful Waiting, Parathyroid Gland Surgery)), By End Use (Hospitals & Clinics, Ambulatory Surgical Centers), And Segment Forecasts To 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1 Methodology & Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Market Summary
Chapter 4 Market Variables, Trends& Scope
4.1 Market Segmentation & Scope
4.1.1 Market Driver Analysis
4.1.2 Market Restraint Analysis
4.2 Penetration & Growth Prospect Mapping
4.3 Urolithiasis Management Devices Market – SWOT Analysis, By Factor (political & legal, economic and technological)
4.4 Industry Analysis – Porter’s
Chapter 5 Market Categorization 1: Treatment Type Estimates & Trend Analysis
5.1 Urolithiasis Management Devices market: Treatment Type movement analysis
5.2 Extracorporeal Shock Wave Lithotripsy (ESWL)
5.2.1 Extracorporeal shock wave lithotripsy (ESWL) market, 2013 – 2024 (USD Million)
5.3 Intracorporeal Lithotripsy
5.3.1 Intracorporeal lithotripsy market, 2013 – 2024 (USD Million)
5.4 Percutaneous Nephrolithotomy
5.4.1 Percutaneous nephrolithotomy market, 2013 – 2024 (USD Million)
5.5 Other Treatments
5.5.1 Other treatments market, 2013 – 2024 (USD Million)
Chapter 6 Market Categorization 2: End-Use Estimates & Trend Analysis
6.1 Urolithiasis Management Devices market: End-Use movement analysis
6.2 Hospitals & Clinics
6.2.1 Hospitals & Clinics market, 2013 – 2024 (USD Million)
6.3 Ambulatory Surgical Centers
6.3.1 Ambulatory Surgical Centers market, 2013 – 2024 (USD Million)
Chapter 7 Market Categorization 3: Regional Estimates & Trend Analysis, by Treatment Type, and End-Use
7.1 Urolithiasis Management Devices market share by region, 2013 & 2024
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 UK
7.3.2 Germany
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.5 Latin America
7.5.1 Mexico
7.5.2 Brazil
7.6 MEA
7.6.1 South Africa
Chapter 8 Competitive Landscape
8.1 Strategy framework
8.2 Company Profiles
8.2.1 Allengers Medical Systems Ltd.
8.2.1.1 Company Overview
8.2.1.2 Financial Performance
8.2.1.3 Product Benchmarking
8.2.1.4 Strategic Initiatives
8.2.2 Boston Scientific Corporation
8.2.2.1 Company Overview
8.2.2.2 Financial Performance
8.2.2.3 Product Benchmarking
8.2.2.4 Strategic Initiatives
8.2.3 C.R. Bard, Inc.
8.2.3.1 Company Overview
8.2.3.2 Financial Performance
8.2.3.3 Product Benchmarking
8.2.3.4 Strategic Initiatives
8.2.4 Cook Medical
8.2.4.1 Company Overview
8.2.4.2 Financial Performance
8.2.4.3 Product Benchmarking
8.2.4.4 Strategic Initiatives
8.2.5 ConMed Corporation
8.2.5.1 Company Overview
8.2.5.2 Financial Performance
8.2.5.3 Product Benchmarking
8.2.5.4 Strategic Initiatives
8.2.6 DirexGroup
8.2.6.1 Company Overview
8.2.6.2 Financial Performance
8.2.6.3 Product Benchmarking
8.2.6.4 Strategic Initiatives
8.2.7 Dornier MedTech GmbH
8.2.7.1 Company Overview
8.2.7.2 Financial Performance
8.2.7.3 Product Benchmarking
8.2.7.4 Strategic Initiatives
8.2.8 Guangzhou Potent Optotronic Technology Co., Ltd.
8.2.8.1 Company Overview
8.2.8.2 Financial Performance
8.2.8.3 Product Benchmarking
8.2.8.4 Strategic Initiatives
8.2.9 HealthTronics, Inc.
8.2.9.1 Company Overview
8.2.9.2 Financial Performance
8.2.9.3 Product Benchmarking
8.2.9.4 Strategic Initiatives
8.2.10 Karl Storz GmbH & Co. KG
8.2.10.1 Company Overview
8.2.10.2 Financial Performance
8.2.10.3 Product Benchmarking
8.2.10.4 Strategic Initiatives
8.2.11 Lumenis
8.2.11.1 Company Overview
8.2.11.2 Financial Performance
8.2.11.3 Product Benchmarking
8.2.11.4 Strategic Initiatives
8.2.12 Olympus Corporation
8.2.12.1 Company Overview
8.2.12.2 Financial Performance
8.2.12.3 Product Benchmarking
8.2.12.4 Strategic Initiatives
8.2.13 Richard Wolf
8.2.13.1 Company Overview
8.2.13.2 Financial Performance
8.2.13.3 Product Benchmarking
8.2.13.4 Strategic Initiatives
8.2.14 Siemens Healthcare
8.2.14.1 Company Overview
8.2.14.2 Financial Performance
8.2.14.3 Product Benchmarking
8.2.14.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:尿路結石管理機器の世界市場分析:治療別(体外衝撃波砕石術(ESWL)、体内砕石術、経皮的腎結石、他の治療(経過観察、副甲状腺手術))、エンドユーザー別(病院・診療所、外来手術センター)、セグメント予測
■ 英文:Urolithiasis Management Devices Market Analysis By Treatment Type (Extracorporeal Shock Wave Lithotripsy (Eswl), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatments (Watchful Waiting, Parathyroid Gland Surgery)), By End Use (Hospitals & Clinics, Ambulatory Surgical Centers), And Segment Forecasts To 2024
■ 発行日:2016年10月11日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707871
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。